Δ9-Tetrahydrocannabinol and Its Major Metabolite Δ9-Tetrahydrocannabinol-11-oic Acid as 15-Lipoxygenase Inhibitors
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 100 (3) , 1206-1211
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis UseTherapeutic Drug Monitoring, 2006
- Low dose oral cannabinoid therapy reduces progression of atherosclerosis in miceNature, 2005
- Marijuana extracts possess the effects like the endocrine disrupting chemicalsToxicology, 2005
- The diversity of the lipoxygenase familyFEBS Letters, 1999
- The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient miceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- In vivo and in vitro metabolism of cannabidiol monomethyl ether and cannabidiol dimethyl ether in the guinea pig: On the formation mechanism of cannabielsoin-type metabolite from cannabidiol.Chemical and Pharmaceutical Bulletin, 1990
- Determination of Δ1‐tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography–mass spectrometryBiomedical Chromatography, 1989
- Δ6-Tetrahydrocannabinol-7-oic acid, a urinary Δ6-THC metabolite: Isolation and synthesisCellular and Molecular Life Sciences, 1973
- Forensic Chemical Study on Marihuana. I. A Detection Method of the Principal Constituents by Thin-layer and Gas ChromatographiesChemical and Pharmaceutical Bulletin, 1968